Certificate Number

GMPC or Non Compliance

Site Name

Site Address

City

Postcode

Country

Total Records 891 to 900 of 1047
Download
GMP Search Results
Certificate Number GMPC or Non-compliance Site Details Country Inspection Date
UK MIA 11387 Insp GMP/IMP 11387/27444-0021[H] GMPC

GUY'S AND ST THOMAS' NHS FOUNDATION TRUST, PHARMACY PRODUCTION UNIT, GUY'S HOSPITAL, GREAT MAZE POND, LONDON, SE1 9RT, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 11387 Insp GMP/IMP 11387/351560-0002[I] GMPC

RADIOPHARMACY UNIT, RADIOPHARMACY UNIT, NUCLEAR MEDICINE, GUY'S HOSPITAL, GREAT MAZE POND, LONDON, SE1 9RT, UNITED KINGDOM

UNITED KINGDOM
UK MIA 735 Insp GMP 735/9257473-0003[H] GMPC

BOC BIRTLEY, SHIELD GATE HOUSE, SHADON WAY, PORTOBELLO INDUSTRIAL ESTATE, BIRTLEY, CHESTER LE STREET, DH3 2SW, UNITED KINGDOM

UNITED KINGDOM
UK MIA 40556 Insp GMP/GDP 40556/5518568-0005[H] GMPC

PRIMIUS LAB LIMITED, GROUND FLOOR OFFICE SUITE, 48 BRITANNIA STREET, LONDON, WC1X 9BS, UNITED KINGDOM

UNITED KINGDOM
UK MIA 33652 Insp GMP/GDP 31363/357107-0011[H] GMPC

PHARMARAM LIMITED, UNIT F4, IVANHOE BUSINESS PARK, TOM BILL WAY, ASHBY-DE-LA-ZOUCH, LE65 2UY, UNITED KINGDOM

UNITED KINGDOM
UK MIA 42671 Insp GMP 42671/13896012-0003[H] GMPC

COX PHARMACEUTICAL LIMITED, UNIT 130-131, JOHN PLAYER BUILDING, STIRLING ENTERPRISE PARK, PLAYERS ROAD, STIRLING, FK7 7RP, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 32611 Insp GMP/IMP 32611/105359-0004[I] GMPC

JOHN GOLDMAN CENTRE FOR CELLULAR THERAPY, HAMMERSMITH HOSPITAL, DU CANE ROAD, LONDON, W12 0HS, UNITED KINGDOM

UNITED KINGDOM
UK MIA 4 Insp GMP/IMP 4/310283-0007[H] GMPC

GLAXO OPERATIONS UK LIMITED, GUNNELS WOOD ROAD, STEVENAGE, SG1 2NY, UNITED KINGDOM

UNITED KINGDOM
UK GMP 4 Insp GMP 4/310283-0011[H] GMPC

GLAXO OPERATIONS UK LIMITED, GUNNELS WOOD ROAD, STEVENAGE, SG1 2NY, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 12893 Insp GMP/IMP 12893/117868-0017[I] GMPC

UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST, BRISTOL ROYAL INFIRMARY, MARLBOROUGH STREET, BRISTOL, BS2 8HW, UNITED KINGDOM

UNITED KINGDOM

Due to the restrictions caused by COVID-19, the period of validity GMP and GDP certificates issued by MHRA is automatically extended until the end of 2024, except where clarifying remarks in the document state otherwise. Manufacturers, importers and distributors must continue to comply with GMP/GDP and all other legal obligations. On-site inspections are now being conducted and scheduling of these inspections may be independent of the extended validity period stated above. MHRA reserve the right to perform risk based supervision of sites by either on-site inspections or distant assessments and, based on the outcome, may continue to issue, withdraw or restrict GMP and GDP certificates, as appropriate.

Download XLSX